Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal and Open-label Extension Study Followed by Long-term Open-label Treatment Cycles to Assess the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Chronic Spontaneous Urticaria Patients Who Completed the Preceding Remibrutinib Phase 3 Studies
INTERVENTIONAL
Inicio: 9 de dic de 2022
ID: NCT05513001
Terminado
ClinicalTrials.gov
Efficacy of Tannin Specific Natural Extract for Coronavirus Disease (COVID-19): Randomized Controlled Trial
INTERVENTIONAL
Inicio: 12 de jun de 2020
ID: NCT04403646
Completado
Fase 3
ClinicalTrials.gov
A Comparative Study of Chronic Hepatitis B Subjects Treated With Entecavir Plus Tenofovir Combination Therapy vs. Entecavir Monotherapy in Adults Who Are Treatment-Naive to Nucleosides and Nucleotides: The BE-LOW Study
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00410072
Completado
ClinicalTrials.gov
COVID-19 in People Living With HIV: Evaluation of Risk Factors and Outcomes in Resource-limited Settings. A Pooled Substudy of ADVANCE, D²EFT, DolPHIN2 and NAMSAL
OBSERVATIONAL
Inicio: 12 de ago de 2020
ID: NCT04371835
Completado
ClinicalTrials.gov
Assessment of Effectiveness of Dry Needling for Treating Shoulder Pain: a Randomized Controlled Trial
INTERVENTIONAL
Inicio: 1 de oct de 2018
ID: NCT05137106
Completado
Fase 4
ClinicalTrials.gov
A Randomised Open-label Study Comparing the Safety and Efficacy of Ritonavir Boosted Lopinavir and 2-3N(t)RTI Backbone Versus Ritonavir Boosted Lopinavir and Raltegravir in Participants Virologically Failing First-line NNRTI/2N(t)RTI Therapy
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00931463
Completado
Fase 2
ClinicalTrials.gov
A Exploratory Phase II Clinical Trial, Double-blind, Randomized Placebo-controlled to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
INTERVENTIONAL
Inicio: 6 de ene de 2021
ID: NCT04903184
Completado
Fase 2
ClinicalTrials.gov
Phase-II Immunogenicity Study of a DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO at 2, 4, and 6 Months of Age in Healthy Argentinean Infants
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00831311
Completado
Fase 3
ClinicalTrials.gov
A Phase 3b, Randomized, Open-label Study of the Antiviral Activity and Safety of Dolutegravir Compared to Lopinavir/Ritonavir Both Administered With Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1 Infected Adult Subjects With Treatment Failure on First Line Therapy
INTERVENTIONAL
Inicio: 11 de dic de 2014
ID: NCT02227238
Desconocido
Fase 2
ClinicalTrials.gov
Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina
INTERVENTIONAL
Inicio: 3 de ago de 2021
ID: NCT04988048
Completado
ClinicalTrials.gov
A Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)
OBSERVATIONAL
ID: NCT00027352
Activo, no recluta
Fase 3
ClinicalTrials.gov
Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 9 de dic de 2009
ID: NCT00980538
Completado
Fase 4
ClinicalTrials.gov
MAESTRAL - A Prospective, Multinational, Multicenter, Randomized, Double Blind, Double Dummy, Controlled Study Comparing the Efficacy and Safety of Moxifloxacin to That of Amoxicillin Clavulanic Acid for the Treatment of Subjects With Acute Exacerbations of Chronic Bronchitis.
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00656747
Completado
Fase 3
ClinicalTrials.gov
A Phase 3b, Non-randomized, Open Label, Multi-country, Cohort Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies (RSV MAT-001, RSV MAT-004, RSV MAT-010, RSV MAT-011, RSV MAT-009, RSV MAT-012 and RSV MAT-039) During Any Pregnancy Conceived Post Vaccination/Control
INTERVENTIONAL
Inicio: 7 de feb de 2023
ID: NCT05705440
Por invitación
ClinicalTrials.gov
EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV
OBSERVATIONAL
Inicio: 1 de ene de 1994
ID: NCT02699736
Terminado
Fase 1 temprana
ClinicalTrials.gov
Phase 1 Suicide Plus Immune Gene Therapy for Advanced Melanoma
INTERVENTIONAL
Inicio: 20 de feb de 2020
ID: NCT03338777
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-Blind, Multicenter Study to Compare the Safety and Efficacy of Viramidine to Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
INTERVENTIONAL
Inicio: 1 de jun de 2004
ID: NCT00093093
Completado
Fase 4
ClinicalTrials.gov
Efficacy of Dolutegravir Plus Lamivudine Compared to Dolutegravir Plus Tenofovir/Emtricitabine in HIV-1-infected Treatment-naïve Adults Without Baseline Genotyping Test (D2ARLING Study)
INTERVENTIONAL
Inicio: 17 de nov de 2020
ID: NCT04549467
Completado
Fase 4
ClinicalTrials.gov
A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline Versus Ceftriaxone Plus Vancomycin in Pediatric Subjects With Complicated Community-acquired Bacterial Pneumonia (CABP)
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01669980
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Double-Blind, Randomized, Phase 2 Study to Compare the Safety and Efficacy of Intravenous CXA 101/ Tazobactam and Metronidazole With That of Meropenem in Complicated Intraabdominal Infections
INTERVENTIONAL
Inicio: 25 de jun de 2010
ID: NCT01147640
Anterior
1
...
37
38
39
...
434
Siguiente
Filtros